[OPINION] New Cancer Research Law Brings Hope To Those Affected By Disease

NJTODAY.NET's online business directory

Thanks to the hard work and persistence by pancreatic cancer
advocates, the U.S. Congress recently passed historic legislation that
will finally bring hope to those affected by the disease. The
Recalcitrant Cancer Research Act, formerly known as the Pancreatic
Cancer Research and Education Act, passed Congress as part of the
National Defense Authorization Act, on Dec. 21, 2012.

This legislation means we are one step closer to creating a national
strategy for combating pancreatic cancer, developing early detection
tools and effective treatments and improving the lives of those
affected by this devastating disease.  Pancreatic cancer is
anticipated to move from the fourth leading cause of cancer death to
the second leading cause of cancer death by 2020, possibly as early as
2015. Congress’ support of this bill means we can create a national
plan to begin to reverse this trend.

Congressmen Frank Pallone, Leonard Lance, Robert Menendez, and Frank
Lautenberg played a critical role in helping the landmark legislation
reach the finish line.  On behalf of all those affected by pancreatic
cancer, they have our sincere gratitude.

Todd Cohen
Volunteer Media Representative
Northern New Jersey Affiliate of the
Pancreatic Cancer Action Network

Edison


Connect with NJTODAY.NET


Join NJTODAY.NET's free Email List to receive occasional updates delivered right to your email address!
Email ads@njtoday.net for advertising information Send stuff to NJTODAY.NET Like Us On Facebook Follow Us On Twitter Download this week's issue of NJTODAY.NET